Topical antidepressants: The new local anesthetics?

Regional Anesthesia and Pain Medicine

Volumn 28, Issue 4, 2003, Pages 268-270

  Strümper, Danja ^a   Durieux, Marcel E ^b  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; BUPIVACAINE; DOXEPIN; LOCAL ANESTHETIC AGENT;

ANTIINFLAMMATORY ACTIVITY; ANTINOCICEPTION; APOPTOSIS; CARDIOTOXICITY; CHRONIC PAIN; DRUG ABSORPTION; EDITORIAL; ERYTHEMA; HUMAN; LOCAL ANESTHESIA; PRIORITY JOURNAL; PRURITUS; SIDE EFFECT; SKIN IRRITATION;

EID: 10744221416     PISSN: 10987339     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1098-7339(03)00194-9     Document Type: Article

References (15)

1. Watson CP. Antidepressant drugs as adjuvant analgesics. J Pain Symptom Manage 1994;9:392-405.
2. Xia Z, DePierre JW, Nassberger L. Tricyclic antidepressants inhibit IL-6, IL-1 beta and TNF-alpha release in human blood monocytes and IL-2 and interferon-gamma in T cells. Immunopharmacology 1996;34:27-37.
3. Lanquillon S, Krieg JC, Bening-Abu-Shach U, Vedder H. Cytokine production and treatment response in major depressive disorder. Neuropsychopharmacology 2000;22:370-379.
4. Barber MJ, Starmer CF, Grant AO. Blockade of cardiac sodium channels by amitriptyline and diphenylhydantoin: Evidence for two use-dependent binding sites. Circ Res 1991;69:677-696.
5. Pancrazio JJ, Kamatchi GL, Roscoe AK, Lynch C 3rd. Inhibition of neuronal Na+ channels by antidepressant drugs. J Pharmacol Exp Ther 1998;284:208-214.
6. Gerner P, Mujtaba M, Sinnott CJ, Wang GK. Amitriptyline versus bupivacaine in rat sciatic nerve blockade. Anesthesiology 2001;94:661-667.
7. Khan MA, Gerner P, Kuo Wang G. Amitriptyline for prolonged cutaneous analgesia in the rat. Anesthesiology 2002;96:109-116.
8. McCleane G. Topical application of doxepin hydrochloride, capsaicin and a combination of both produces analgesia in chronic human neuropathic pain: A randomized, double-blind, placebo-controlled study. Br J Clin Pharmacol 2000;49:574-579.
9. McCleane G. Topical application of doxepin hydrochloride can reduce the symptoms of complex regional pain syndrome: A case report. Injury 2002;33:88-89.
10. Epstein JB, Truelove EL, Oien H, Allison C, Le ND, Epstein MS. Oral topical doxepin rinse: Analgesic effect in patients with oral mucosal pain due to cancer or cancer therapy. Oral Oncol 2001;37:632-637.
11. Slamon ND, Pentreath VW. Antioxidant defense against antidepressants in C6 and 1321N1 cells. Chem Biol Interact 2000;127:181-199.
12. Khan MA, Gerner P, Kuo Wang G. Amitriptyline for prolonged cutaneous analgesia in the rat. Anesthesiology 2002;96:109-116.
13. Xia Z, Lundgren B, Bergstrand A, DePierre JW, Nassberger L. Changes in the generation of reactive oxygen species and in mitochondrial membrane potential during apoptosis induced by the antidepressants imipramine, clomipramine, and citalopram and the effects on these changes by Bcl-2 and Bcl-X(L). Biochem Pharmacol 1999;57:1199-1208.
14. Zell-Kanter M, Toerne TS, Spiegel K, Negrusz A. Doxepin toxicity in a child following topical administration. Ann Pharmacother 2000;34:328-329.
15. Bonnel RA, La Grenade L, Karwoski CB, Beitz JG. Allergic contact dermatitis from topical doxepin: Food and Drug Administration's postmarketing surveillance experience. J Am Acad Dermatol 2003;48:294-296.